Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My thoughts exactly. The product and it's value to the market will be the catalyst. Let's talk Prolanta Redman!!!!!!!!!
Just like I stated this past weekend, Redman and ONCX are painted in a corner now. PR's about Prolanta and the trials are what shareholders want to see and hear about now. Nothing else matters.
APPOINT SOMEONE OLDER THAN DIRT JUST TO UPLIST TO OTCQB. C'MON REDMAN!!! TICKER CHANGE, NO INCREASE IN PPS!!! NEW BOARD MEMBER, NO INCREASE IN PPS!!! UPLIST TO OTCQB, NO INCREASE IN PPS!!!
IT'S PROLANTA EVERYBODY WANTS TO HEAR ABOUT!!!!!!!!!!!!
Redman and ONCX are painted in a corner now. PR's about Prolanta and the trials are what shareholders want to see and hear about now. Nothing ese matters.
I would buy 1,000,000 shares of ONCX if Redman would release a PR that stated Prolanta was being manufactured for trials, but until he does this thing has the look and smell of a scam.
Agree 100%...the real meat and potatoes of Oncolix is Prolanta. Get Prolanta going and then you got something for people to invest in. All the other BS about getting another board member so they can uplist, attending conferences, making presentations at conferences, seeking an Asian partner, etc....interesting stuff, but it all means nothing as far as the future share price is concerned and has been evident in the past.
Biggest bunch of BS I've read on this site in a long time...LOL
New name just filed with FINRA....Onscamix
Ticker change and then lose money. What do you expect when you have a University of Phoenix grad running the company.
LOL!!!!!!!!!!!!!
"I do not believe that the company’s valuation reflects the value of the company and its lead asset, Prolanta. It is my belief that the short-term milestones that I will outline below should address this issue."
The list of short-term milestones did not include manufacturing more Prolanta for future trials. Why not??????
Great post! Should sticky this.
Spot on!!!!
OLD NEWS
Ticker change and already ran out of gas....LOL YEEEEEEEHAW!!!!!
Enjoy while it lasts....once the excitement about ticker change wears off back to .05 probably next week....LOL
Big buyers too smart to touch this one....LOL
Pure BS!!!
Do your own DD!!!!!!!!!
Symbol change probably be end of December or first of January since Oncolix had to recently amend a filing and re-apply for ticker change with FINRA.
Amazing how this company burns thru $$$$$ like it's water, especially when nothing is going on....lol
Pure BS!!!
"There simply is no way that a complete conversion of all outstanding notes become issued and sold into the float for many months to come and when it does it will be a very slow drip over a quarterly basis. NEVER all at once."
Investors of Oncolix are legal loan sharks preying on the common stockholders.
This is worth zero!!! Total BS!!! Nobody would give out such information....lol
NO Ticker Change, NO News, NO Volume. Still NO worries??? LOL YEEEEEEHAW!!!!
INVENTOR_NO_LONGER_ASSOCIATED_WITH_ONCOLIX
ALL_PATENTS_WORTHLESS
Time out!!! The US government is NOT and has NOT funded or invested in this pos. The Texas Treasury is holding shares and they are holding them for someone who does not want to reveal hiself or herself.
Great post!
Just absolutely disgusting that these people disguise themselves and use a failed cancer drug as a means to con investors!!!!!! $2,899,267 net cash provided by financing activities as stated in September 30th quarterly report. Of that, $2,000,000 was cash just received from convertible notes on August 3rd. Now there is $1,360,588 cash and equivalents stated in September 30th quarterly. Where did $1,538,679 go in less than 2 months????
FINRA application for symbol change had to be resubmitted. First quarter report for 2017 had to be amended and refiled. Ticker change delayed at least until end of December. The fact that Oncolix has a CUSIP number has nothing to do with ticker change. CUISP is just a tracking number.
$2,899,267 net cash provided by financing activities on September 30th of which $2,000,000 was cash received from convertible notes on August 3rd. $1,360,588 cash and equivalents on September 30th. $1,538,679 vanishes in less than 2 months. Run while you can!!!!!!
Simple, just con more investors into believing this is a real merger and a company with a real cancer drug. Interest payments taken care of....lol.
November 1st. Time for interest payment to be made. Slow descent to .0001 is inevitable.
2017 1Q filing had to be amended and refiled. Ticker change delayed at least 30 days or more. The fact that Oncolix has a CUSIP number has nothing to do with ticker change.
Ticker change delayed!!!! 1Q report had to be amended and re-filed. Oncolix had to reapply for ticker change. At least another 30 days for change...lol
Ticker change delayed...lol. Amended 1Q report caused Oncolix to reapply for ticker change. At least another 30 days for change...lol
Interest expense for convertible notes for first quarter = $181,394 ($725,576 per year). First quarterly payment due in less than 5 days on November 1, 2017. Payment will be in common stock. Per filings, if price per share calculates to .05 (probably will be lower) quarterly payment = 3,620,000+ shares issued on November 1, 2017.
Prolanta already a failure, hope for your sake they have something else up their sleeve.
Anybody know how long it took FINRA to get symbol changed? I hear they are way behind
.0001
Just like clockwork
..green on a Friday red on Monday. So pathetic...lol